Prescribing Antiepileptic Drugs: Should Patients Be Switched on the Basis of Cost?

Author： Barbara C. Jobst Gregory L. Holmes

ISSN： 1172-7047

Source： CNS Drugs, Vol.18, Iss.10, 2004-01, pp. : 617-628

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Should Antiepileptic Drugs Be Withdrawn in Seizure-Free Patients?

By Specchio L.M.

CNS Drugs, Vol. 18, Iss. 4, 2004-01 ,pp. : 201-212

Adis International

Access to resources Recommend Favorite

Teratogenic Potential of the Newer Antiepileptic Drugs: What is Known and How Should This Influence Prescribing?

By Palmieri C. Canger R.

CNS Drugs, Vol. 16, Iss. 11, 2002-01 ,pp. : 755-764

Adis International

Access to resources Recommend Favorite

Newer drugs for rheumatoid arthritis worth their cost?

PharmacoEconomics and Outcomes News, Vol. 1, Iss. 338, 2001-01 ,pp. : 5-5

Adis International

Access to resources Recommend Favorite

Epoetin- in heart surgery patients - not worth the cost?

PharmacoEconomics and Outcomes News, Vol. 1, Iss. 283, 2000-01 ,pp. : 6-6

Adis International

Access to resources Recommend Favorite

Suicidality and Antiepileptic Drugs: Is there a Link?

By Kalinin Vladimir V.

Drug Safety, Vol. 30, Iss. 2, 2007-01 ,pp. : 123-142

Adis International

Access to resources Recommend Favorite